Literature DB >> 9135386

Prevalence of diabetic retinopathy in patients with diabetes mellitus diagnosed after the age of 70 years.

M Cahill1, A Halley, M Codd, N O'Meara, R Firth, D Mooney, R W Acheson.   

Abstract

AIMS/
BACKGROUND: A hospital based prevalence study was undertaken to estimate the prevalence of diabetic retinopathy (DR) in patients diagnosed as having diabetes mellitus after the age of 70 years. The prevalence of visually threatening retinopathy at the time of diagnosis of diabetes was also determined. The association between prevalence of DR and duration of diabetes mellitus, mode of treatment, HbA1c levels, presence of hypertension, and sex of patient was examined and a comparison was drawn between this study and earlier prevalence studies of DR in older type II diabetics.
METHODS: Using data on the Irish Diabetic Retinopathy Register located in the Mater Misericordiae Hospital, Dublin, all patients who were diagnosed as having type II diabetes mellitus after the age of 70 years were invited to attend for ophthalmic review. Medical records were examined to determine the duration of diabetes mellitus, mode of treatment, recent HbA1c levels, and the presence of systemic hypertension.
RESULTS: Of the 150 patients examined, 21 (14%) had some form of DR and 10 of these patients (6.6%) had visually threatening retinopathy or previously treated visually threatening retinopathy. Five patients (3.3%) presented with visually threatening retinopathy at the time of diagnosis of diabetes. Those patients with DR had a significantly higher median duration of diabetes (5.0 years) compared with those patients without DR (3.5 years). A significantly higher proportion of patients with DR required treatment with insulin and a correspondingly lower proportion of patients without DR were controlled on diet alone. There was no significant association between prevalence of DR and HbA1c levels, systemic hypertension, or sex of patient. There was a lower overall prevalence of DR in comparison with earlier studies.
CONCLUSIONS: The prevalence of DR in these elderly type II diabetics is lower than than previously reported in patients with type II disease but a small percentage of patients had visually threatening retinopathy at presentation. Longer duration of diabetes and insulin use were associated with a significantly increased prevalence of DR. All elderly type II diabetic patients require thorough ophthalmic examination near to the time of first presentation and thereafter at regular intervals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9135386      PMCID: PMC1722137          DOI: 10.1136/bjo.81.3.218

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  19 in total

1.  Prevalence of diabetic retinopathy. Age, sex, and duration of diabetes.

Authors:  H A Kahn; R F Bradley
Journal:  Br J Ophthalmol       Date:  1975-07       Impact factor: 4.638

2.  Prevalence of diabetes mellitus in southern Wisconsin.

Authors:  R Klein; B E Klein; S E Moss; D L DeMets; I Kaufman; P S Voss
Journal:  Am J Epidemiol       Date:  1984-01       Impact factor: 4.897

3.  Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients.

Authors:  M A Gall; P Rossing; P Skøtt; P Damsbo; A Vaag; K Bech; A Dejgaard; M Lauritzen; E Lauritzen; P Hougaard
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

4.  Comparison of diabetic retinopathy detection by clinical examinations and photograph gradings. Barbados (West Indies) Eye Study Group.

Authors:  A P Schachat; L Hyman; M C Leske; A M Connell; C Hiner; N Javornik; J Alexander
Journal:  Arch Ophthalmol       Date:  1993-08

5.  Prevalence and 15-year incidence of retinopathy and associated characteristics in middle-aged and elderly diabetic men.

Authors:  L Yanko; U Goldbourt; I C Michaelson; A Shapiro; S Yaari
Journal:  Br J Ophthalmol       Date:  1983-11       Impact factor: 4.638

6.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

7.  The prevalence of retinopathy and associated medical risk factors in type I (insulin-dependent) diabetes mellitus.

Authors:  E Agardh; O Torffvit; C D Agardh
Journal:  J Intern Med       Date:  1989-07       Impact factor: 8.989

8.  Detection of diabetic macular edema. Ophthalmoscopy versus photography--Early Treatment Diabetic Retinopathy Study Report Number 5. The ETDRS Research Group.

Authors:  J Kinyoun; F Barton; M Fisher; L Hubbard; L Aiello; F Ferris
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

9.  Is blood pressure a predictor of the incidence or progression of diabetic retinopathy?

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Intern Med       Date:  1989-11

10.  Retinopathy at diagnosis of diabetes, with special reference to patients under 40 years of age.

Authors:  N G Soler; M G Fitzgerald; J M Malins; R O Summers
Journal:  Br Med J       Date:  1969-09-06
View more
  4 in total

1.  Evaluating digital diabetic retinopathy screening in people aged 90 years and over.

Authors:  A Tye; H Wharton; A Wright; Y Yang; J Gibson; A Syed; A Mills; P Dodson
Journal:  Eye (Lond)       Date:  2015-07-17       Impact factor: 3.775

2.  Causes of blindness in the adult population of the Republic of Ireland.

Authors:  A Munier; T Gunning; D Kenny; M O'Keefe
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

3.  Prevalence and risk factors of diabetic retinopathy in adult and elderly subjects: The Casteldaccia Eye Study.

Authors:  Giuseppe Giuffrè; Gaetano Lodato; Gabriella Dardanoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-02-18       Impact factor: 3.117

4.  Prevalence of dry eye syndrome and diabetic retinopathy in type 2 diabetic patients.

Authors:  Masoud Reza Manaviat; Maryam Rashidi; Mohammad Afkhami-Ardekani; Mohammad Reza Shoja
Journal:  BMC Ophthalmol       Date:  2008-06-02       Impact factor: 2.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.